000 | 01934 a2200553 4500 | ||
---|---|---|---|
005 | 20250516004130.0 | ||
264 | 0 | _c20110203 | |
008 | 201102s 0 0 eng d | ||
022 | _a1029-2403 | ||
024 | 7 |
_a10.3109/10428194.2010.506569 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHashimoto, Kenji | |
245 | 0 | 0 |
_aPneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cOct 2010 |
||
300 |
_a1816-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCD4-CD8 Ratio |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma, B-Cell _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPneumocystis carinii _xdrug effects |
650 | 0 | 4 |
_aPneumonia, Pneumocystis _xcomplications |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xtherapeutic use |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aKobayashi, Yukio | |
700 | 1 | _aAsakura, Yoshitaka | |
700 | 1 | _aMori, Masakazu | |
700 | 1 | _aAzuma, Teruhisa | |
700 | 1 | _aMaruyama, Dai | |
700 | 1 | _aKim, Sung-Won | |
700 | 1 | _aWatanabe, Takashi | |
700 | 1 | _aTobinai, Kensei | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 51 _gno. 10 _gp. 1816-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428194.2010.506569 _zAvailable from publisher's website |
999 |
_c20225962 _d20225962 |